Investigating the link between HIV infection and male hypogonadism

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study examines the prevalence of hypogonadism among HIV-infected men who have sex with men (MSM) by comparing them to an age-matched group of non-HIV infected MSM. It aims to identify risk factors associated with male hypogonadism, including age, duration of HIV infection, comorbidities, body mass index (BMI), and antiretroviral therapy (ART) use. Additionally, the study will explore the correlation between serum testosterone levels and various health aspects such as sexual function, vitality, exercise capacity, mood, and bone mineral density.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* HIV-infected men who have sex with men
* HIV non-infected men

Exclusion Criteria:

* Use of testosterone supplement, anabolic steroid in the past one year.
* History of pituitary , adrenal or gonad diseases
* History of pituitary surgery or radiation therapy
* History of systemic chemotherapy
* Active opportunistic infection under treatment
* Cancer
* Severe hepatic, renal or cardiac impairment

Where it's running

• National Taiwan University Hospital
  Taipei, Taiwan Recruiting

Study contacts

• Study coordinator: Shyang-Rong Shih, Ph.D.
• Email: srshih@ntu.edu.tw
• Phone: +886-2-2312-3456

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Comparing oral and transdermal estrogen therapy in women with Turner syndrome

  This study is testing whether taking estrogen as a pill or through the skin is better for women with Turner syndrome in terms of their overall health and well-being.

  Recruiting Phase 4 University of Aarhus · Aarhus, Aarhus N · NCT06570460

• Comparing oral and transdermal estrogen treatment in women with Turner syndrome

  This study is testing whether taking estrogen by mouth or through the skin works better for women with Turner syndrome.

  Recruiting Phase 4 University of Aarhus · Aarhus, Aarhus N · NCT06544473

• SI-B036 safety test in advanced and metastatic solid tumors

  This early-phase study checks whether SI-B036 is safe and tolerable in adults with advanced or metastatic solid cancers who have had prior therapy.

  Recruiting at 4 sites Phase 1 SystImmune Inc. · New Haven, Connecticut and 6 other locations · NCT07857616

• Men's experiences with ICSI and low sperm quality

  This project will see if Danish men with low sperm quality who undergo ICSI have lower quality of life or low testosterone and how they experience interactions with health professionals.

  Recruiting Regionshospitalet Viborg, Skive · Skive, Midt Jylland · NCT07546435

• Tamoxifen to speed testosterone recovery after ADT in men with prostate cancer

  Tamoxifen is being tested to see if it helps men who have been on androgen deprivation therapy regain normal testosterone faster after treatment.

  Recruiting Phase 2 University Health Network, Toronto · Toronto, Ontario · NCT07535905

• O-RADS MRI classification to predict malignancy of ovarian masses in girls

  This project will test whether the O-RADS MRI classification can help doctors tell if ovarian masses in girls under 16 are benign or malignant before surgery.

  Recruiting University Hospital, Strasbourg, France · Strasbourg · NCT07313514

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.